Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02081534 · ClinicalTrials.gov registry record · Phase 2
Dose Finding Study to Treat High Phosphate Levels in the Blood.
A Phase 2 study, sponsored by Ardelyx.
- Completed
- Registry status
- Phase 2
- Development phase
- 162
- Enrollment target
NCT02081534 is a Phase 2 study that has completed, run by Ardelyx. The registered enrollment target is 162 participants.
The verdict
NCT02081534, a Phase 2 study, has completed, sponsored by Ardelyx.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 162 participants
- Enrollment target
Study Summary
Randomized. double blind, placebo controlled, parallel arms dose finding study with a 4 weeks treatment period
Interventions
- DRUG Placebo
- DRUG AZD1722
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02081534
The ClinicalTrials.gov registry entry for NCT02081534 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ardelyx, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02081534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02081534 about?
NCT02081534 is a clinical study titled "Dose Finding Study to Treat High Phosphate Levels in the Blood.". Randomized. double blind, placebo controlled, parallel arms dose finding study with a 4 weeks treatment period
What is the current status of trial NCT02081534?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 162 participants. The study started on 2014-03. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02081534?
The interventions under investigation include: Placebo (DRUG), AZD1722 (DRUG).
Who is sponsoring clinical trial NCT02081534?
This trial is sponsored by Ardelyx, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.